# Aktinos Pharma Private Limited - Unit II, Pinamadaka, India – FDA Inspections

Source: https://www.keypedia.com/companies/aktinos-pharma-private-limited-unit-ii/81f7ec33-4c2f-4ae8-ac13-851cbc8e1949

> Inspection records and compliance data for Aktinos Pharma Private Limited - Unit II in Pinamadaka, -. 2 FDA inspections on record, 2 Form 483s, last inspected December 12, 2025.

---

## Details

- Name: Aktinos Pharma Private Limited - Unit II
- FEI Number: 3012575874
- Address Line 1: Plot No: 80D, Road No. 20, Jawaharlal Nehru Pharmacity, Parawada
- City: Pinamadaka
- State: -
- Zip Code: -
- Country Name: India
- Address: Plot No: 80D, Road No. 20, Jawaharlal Nehru Pharmacity, Parawada, Pinamadaka, - -, India
- Country: India

## Related Documents

- [483 - Aktinos Pharma Private Limited - Unit II - 2025-12-12](https://www.keypedia.com/records/483/aktinos-pharma-private-limited-unit-ii/404b0eaf-37de-4dee-bf35-ce0d82f00e0e) — source: FDA, date: December 12, 2025
- [FDA Inspection 1294874 - Aktinos Pharma Private Limited - Unit II - 2025-12-12](https://www.keypedia.com/records/fda_inspections/aktinos-pharma-private-limited-unit-ii/7f2882f1-7655-456b-b5c5-0239c7aaff81) — source: FDA, date: December 12, 2025
- FDA Inspection 1294874 - Aktinos Pharma Private Limited - Unit II - 2025-12-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 12, 2025
- [483 - Aktinos Pharma Private Limited - Unit II - 2022-10-14](https://www.keypedia.com/records/483/aktinos-pharma-private-limited-unit-ii/bd161630-0e07-4070-baad-8abd93617895) — source: FDA, date: October 14, 2022
- [FDA Inspection 1071478 - Aktinos Pharma Private Limited - Unit II - 2018-11-01](https://www.keypedia.com/records/fda_inspections/aktinos-pharma-private-limited-unit-ii/ebbb4915-5869-43dd-8790-5815fcdbc93f) — source: FDA, date: November 1, 2018

## Related Companies

- [Contacare Ophthalmics & Diagnostics](https://www.keypedia.com/companies/contacare-ophthalmics-diagnostics/069da802-0ebb-4d3a-b872-db4166bde6d6)
- [Eduardo Yanez Ruiz](https://www.keypedia.com/companies/eduardo-yanez-ruiz/366f1631-d34b-47e8-804b-a3d7d580d0e3)
- [Lin Shen, M.D.](https://www.keypedia.com/companies/lin-shen-md/38ec4e28-dc8d-443d-a07a-09d1c8a4fbf7)
- [Daniel Norman, M.D.](https://www.keypedia.com/companies/daniel-norman-md/bd34bdd0-4f58-4a86-9a6d-0cfc983e300c)
- [Paramesh Banerji Life Sciences, LLC](https://www.keypedia.com/companies/paramesh-banerji-life-sciences-llc/8a5dcf24-e253-4116-a968-f9b1a890d15b)
- [Keith A. Aqua, M.D.](https://www.keypedia.com/companies/keith-a-aqua-md/1b09891f-72da-4ee0-b524-946275c5044f)
- [Macau-Union Pharmaceutical Limited](https://www.keypedia.com/companies/macau-union-pharmaceutical-limited/8d630c2e-bc66-456f-80ff-9e13617bda19)
- [Axsome Therapeutics, Inc.](https://www.keypedia.com/companies/axsome-therapeutics-inc/0bc3d1e2-dfe0-47ba-b144-4248f1fdfdf0)
- [BRI Institutional Review Board, Inc.](https://www.keypedia.com/companies/bri-institutional-review-board-inc/27f73a19-9417-4b75-90db-3cd132eddbb1)
- [OurPharma LLC](https://www.keypedia.com/companies/ourpharma-llc/2172e4a8-770c-45d9-9eb6-0321c8ba396f)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/nadeem-i-chaudhry/7d867939-2dc6-4503-b9b9-6f26b16c347e)
- [Pharmaceutical Program Expert](https://www.keypedia.com/people/zachary-l-stamm/b729fab9-4d31-4c70-b5b3-e8b6207769c6)